Skip to main content

Contineum Therapeutics, Inc 10-K for FY2025

Contineum Therapeutics, Inc. (CTNM)

10-K 2026-03-05 For: 2025-12-31
View Original
Added on April 09, 2026

About this 10-K

Contineum Therapeutics, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$59.98M
compared with a net loss of $42.26M a year earlier
Diluted EPS
-$2.17
compared with -$2.18 a year earlier